Stock Analysis

[clatoden99]

$HTGM is trying to form a base around $6 right now. HTGM is now a buy below $6 for the next big trade.

 

[clatoden99]

Small Cap Bull 3x ($TNA) rallied $10 and is now seeing another sell off. Buy TNA below $90 for the next bounce.

 

[clatoden99]

China 3x Bull ETF (YINN) is slowly dropping back down below $20. YINN is a strong buy below $17 if we ever see another big drop. Resistance will be located up around $21.

 

[clatoden99]

$CMG exploded back above $450 this week. CMG is a buy below $350 over the next three months if we see another dip.

 

[clatoden99]

$SHAK is holding long term support around $30. Shake Shack stores are seeing huge lines as spring is finally here. Expect strong guidance into 2018.

 

[clatoden99]

China 3x Bull ETF ($YINN) is slowly dropping back down below $20. YINN is a strong buy below $17 if we ever see another big drop. Resistance will be located up around $21.

 

[clatoden99]

$HTGM is trying to form a base around $6 right now. HTGM is a buy below $6 for the next big trade.

 

[clatoden99]

Small Cap Bull 3x ($TNA) rallied $10 and is now seeing another sell off. Buy TNA below $90 for the next bounce.

 

[clatoden99]

Shares of MoneyGram ($MGI) are moving notably higher in pre-market trading after Alibaba ($BABA) affiliate Ant Financial increased its offer to acquire the money transfer service to $1.2 billion from $880 million.

 

[clatoden99]

Medical test maker Alere ($ALR) is also seeing pre-market strength after agreeing to an amended merger agreement with Abbott ($ABT) valuing the company at $5.3 billion compared to the original $5.8 billion offer.

 

[clatoden99]

Meanwhile, shares of Eli Lilly ($LLY) and Incyte ($INCY) are under pressure in pre-market trading after the FDA declined to approve their drug for the treatment of moderate-to-severe rheumatoid arthritis.

 

[clatoden99]

Shares of UnitedHealth ($UNH) may see early strength after the health insurer reported better than expected first quarter results and raised its full-year guidance.

 

[clatoden99]

After the close of trading on Monday, Netflix ($NFLX) reported first quarter earnings that came in above analyst estimates. The video streaming service reported revenues that matched expectations.

 

[clatoden99]

On the other hand, Goldman Sachs ($GS) reported weaker than expected first quarter earnings on disappointing trading revenue.

 

[clatoden99]

Shares of Ultragenyx Pharmaceutical ($RARE) are moving sharply higher in pre-market trading after the biopharmaceutical company released positive Phase 3 results for its drug to treat x-linked hypophosphatemia.

 

[clatoden99]

On the other hand, tech giant IBM Corp. ($IBM) may come under pressure after reporting first quarter earnings that beat analyst estimates but on weaker than expected revenues.

 

[clatoden99]

$AMZN I think shorts are going to try hard to have you sell below $900 but hold on , ER is only 7 days away and it will get pushed to $930!

 

[clatoden99]

$AMZN, $AAPL, $MSFT, $FB, $NFLX, $GOOGL, $QQQ only one underperformed the market n its ER is very interesting

 

[clatoden99]

$TSN ER coming and a good setup too. U may give a chance if u like to play ERs try us n get more HQTs

 

[clatoden99]

$TSLA n $AMZN, for now, they look great until their performance widens a good buy together or sell short together